To FDA on labeling of plant-based milk alternatives and voluntary nutrient statements
GFI urges FDA to treat plant-based milks fairly and avoid any labeling scheme that would unfairly burden one class of products in the marketplace.
Posted In:

Comment letters
GFI submits public comments to policymakers in order to advance alternative proteins strategically and with integrity.